top of page
Paul Ford - CEO
Mar 25, 20203 min read
Specialty Drugs, Coronavirus, & the Opportunity to Reduce Cost
The promise of a miracle drug to combat Corvid-19 like Hydroxychloroquine has created polarizing perspectives on the optimism of...
Paul Ford - CEO
Mar 25, 20201 min read
Podcast: OrchestraRx On "Reconstructing Healthcare"
In this episode, Michael Menerey, host of the Reconstructing Healthcare podcast chats with Paul Ford, the Founder, and CEO of...
Paul Ford - CEO
Mar 23, 20203 min read
To Exclude or Not to Exclude?
Excluding drugs from your formulary can save you money, but so can not excluding drugs. In working with Taft-Hartley Union Trust,...
Paul Ford - CEO
Mar 23, 20204 min read
Impact of Corvid-19 on Corporate Benefits: The Uphill Battle Just Got Steeper
Learn about the 3 impacts to corporate benefits in the CORVID-19 age.
bottom of page